AQP4 rs3875089: What Your Genotype Means
The rs3875089 variant is a single-nucleotide polymorphism located within the AQP4 gene, which encodes a protein essential for fluid movement in the brain. Research suggests this variant may influence how sleep quality and duration interact with cognitive decline and brain structure in older adults.
What each genotype means
Potential sleep-moderated cognitive resilience
Research suggests that individuals homozygous for the C allele may experience reduced cognitive decline in the presence of increased sleep disturbances compared to other genotypes. This variant is thought to influence AQP4 expression, which plays a role in the brain's glymphatic clearance system. These findings are context-dependent and based on specific study populations; please discuss any concerns regarding cognitive health or sleep quality with your healthcare provider.
The frequency of this genotype varies significantly across global populations and is not uniformly distributed.
Variable sleep-related cognitive association
This genotype represents a heterozygous state for the rs3875089 variant. While the homozygous C genotype has been linked to specific patterns of cognitive decline in the context of sleep disturbance, the clinical implications for carriers of one C and one T allele are less clearly defined in current literature. Please consult with a medical professional to discuss your overall cognitive health and sleep hygiene.
This genotype is found at varying frequencies depending on ancestral background.
Typical AQP4 variant profile
This genotype represents the alternative homozygous state for the rs3875089 variant. Current research focuses on the potential protective associations of the C allele in the context of sleep-related cognitive decline, meaning this genotype does not share that specific observed association. As with all genetic findings, this should be viewed as one small factor among many; please discuss any health concerns with your clinician.
The prevalence of this genotype is variable and depends on the specific population group being studied.
Understanding the AQP4 Gene and rs3875089
The AQP4 gene provides instructions for creating the aquaporin-4 protein, a water channel found in the brain's astrocytes. These channels are critical components of the glymphatic system, a network that facilitates the clearance of metabolic waste products, including amyloid-beta, from the brain. This clearance process is most active during deep, slow-wave sleep. The variant rs3875089 is a specific change in the DNA sequence of this gene. While many such variants exist, researchers are particularly interested in how this specific SNP might alter the efficiency of the glymphatic system. By studying this variant, scientists aim to understand why some individuals may be more susceptible to the negative cognitive effects of sleep disturbances than others. It is important to note that this variant is just one of many factors that contribute to brain health and cognitive function over a lifetime.
Research Associations and Evidence Strength
Current evidence regarding rs3875089 is considered moderate and is primarily derived from studies investigating the intersection of genetics, sleep, and neuroimaging. Recent research, such as studies utilizing the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort, has observed that AQP4 variants, including rs3875089, may moderate the relationship between sleep patterns and cognitive decline. Specifically, these studies suggest that the impact of sleep latency and quality on brain volume and cognitive performance can differ depending on an individual's AQP4 genotype. While these findings are compelling, they are largely based on observational data in specific cohorts. The scientific community emphasizes that the causal directionality—whether the variant directly causes cognitive changes or simply modulates the brain's response to sleep disruption—remains a subject of ongoing investigation. Consequently, these associations should be viewed as preliminary insights into complex biological pathways rather than definitive predictors of health outcomes.
Population Frequency and Variability
The frequency of the rs3875089 variant is known to be variable across different ancestral populations. Genetic databases indicate that the distribution of the alleles for this SNP is not uniform globally, which is a common characteristic of many genetic variants. Because population frequency can influence the statistical power of genetic studies, researchers often account for ancestry when analyzing these associations. Detailed, large-scale data on the exact percentage of individuals carrying each genotype for rs3875089 across all global populations is still being refined. Consumers should be aware that 'variable' frequency means that the likelihood of carrying a specific genotype depends significantly on one's genetic background. As more diverse genomic data becomes available, our understanding of how this variant is distributed and how it might affect different populations will continue to improve.
Interpreting Your Genetic Information
If you have information about your rs3875089 genotype, it is essential to interpret it within the context of your overall health. This variant is not a diagnostic tool; it does not determine whether you will experience cognitive decline or Alzheimer's disease. Instead, it represents a small piece of a much larger puzzle involving lifestyle, environment, and other genetic factors. Because the research indicates that the effects of this variant are highly context-dependent—often interacting with sleep habits—it highlights the importance of modifiable lifestyle factors. If you are concerned about sleep quality, cognitive changes, or your risk for neurodegenerative conditions, the most effective step is to consult with a healthcare professional. They can provide personalized guidance based on your clinical history, rather than relying on a single genetic marker. Never use genetic information to make medical decisions or alter treatments without professional medical advice.
How common is this variant?
The frequency of the rs3875089 variant is variable across different ancestral populations, with no single genotype being universally dominant.
Frequently asked questions
Does having a specific AQP4 genotype mean I will get Alzheimer's disease?
No. The rs3875089 variant is associated with cognitive and brain-related traits in research studies, but it is not a diagnostic marker for Alzheimer's disease. Many factors, including genetics, lifestyle, and environment, contribute to brain health.
Can I change my risk associated with this variant?
Research suggests that the effects of AQP4 variants may be moderated by sleep quality and duration. Focusing on healthy sleep habits is a modifiable factor that may support overall brain health, regardless of your genetic profile.
What is the glymphatic system?
The glymphatic system is a waste-clearance pathway in the brain that uses aquaporin-4 channels to help remove metabolic byproducts. It is most active during deep sleep.
Should I share my rs3875089 results with my doctor?
You can share any health information with your doctor, but keep in mind that this variant is not currently used for clinical diagnosis. Your doctor will prioritize your clinical symptoms and overall health history.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3875089?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in AQP4
This AQP4 variant moderates the effect of sleep latency on brain amyloid-beta burden and has been linked to altered trajectories of cognitive decline.
This Aquaporin-4 variant is associated with poorer overall sleep quality and moderates the relationship between sleep duration and brain amyloid-beta burden.
This variant in the AQP4 gene moderates the association between sleep duration and brain amyloid-beta burden, where longer sleep duration is linked to higher amyloid levels in minor allele homozygotes.